Omeros | OMER - أرباح التشغيل





أرباح التشغيل تغيير تاريخ
Adma Biologics USD 50.29M 12.46M 2026-03
Alnylam Pharmaceuticals USD 112.6M 24.99M 2026-06
BioMarin Pharmaceutical USD 105.6M 24.04M 2026-06
Cytokinetics USD -179.17M 2.05M 2026-06
Gilead Sciences USD 3.85B 1.17B 2026-06
Heron Therapeutics USD 38K 3.83M 2025-12
Immunic USD -23.33M 2.67M 2025-12
Insmed USD -101.31M 98.97M 2026-06
Knight Therapeutics CAD 6.21M 3.27M 2025-12
MacroGenics USD -33.44M 21.34M 2026-03
Omeros USD -35.41M 23.75M 2024-09
Pacira USD 9.96M 5.33M 2026-06
Pfizer USD 667M 4.32B 2026-06
Rockwell Medical USD 515K 1.84M 2024-06
Sangamo BioSciences USD -33.51M 12.77M 2024-06
Sarepta Therapeutics USD 13.29M 345.14M 2026-06
United Therapeutics USD 330.8M 5M 2026-06
Vertex Pharmaceuticals USD 1.27B 129.9M 2026-06